A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Fetzima is available by prescription only to treat adults with Major Depressive Disorder (MDD).
Fetzima is classified as a serotonin and norepinephrine reuptake inhibitor (SNRI).
Fetzima is available in 20 mg, 40 mg, 80 mg, and 120 mg extended-release capsules for oral use.
Take Fetzima exactly as your doctor has prescribed. If you have any questions or concerns, talk to your doctor or pharmacist.
The recommended starting Fetzima dosage is 20 mg by mouth one time a day for two days, and then increase to 40 mg by mouth one time a day.
The doctor may adjust the dose, up to a maximum of 120 mg once daily, depending on tolerance and response to the medication.
Patients with kidney problems may need a lower dose.
Each Fetzima capsule contains levomilnacipran hydrochloride (HCl). Inactive ingredients include ethylcellulose, hypromellose, povidone, sugar spheres, talc, titanium dioxide, triethyl citrate, black iron oxide, red iron oxide (80 mg and 120 mg capsules), shellac glaze, and yellow iron oxide (20 mg and 40 mg capsules).
Patients who are allergic to levomilnacipran, milnacipran HCl, or to any of the ingredients in Fetzima should not take the medication.
Patients should not take MAOIs for psychiatric disorders with Fetzima or within seven days of stopping Fetzima.
Patients should not take Fetzima within 14 days of stopping an MAOI for psychiatric disorders.
Patients should not take Fetzima with linezolid or methylene blue.
Fetzima has an FDA Boxed Warning about the increased risk of suicidal thoughts or behavior. Patients should be closely monitored while taking Fetzima and treated for clinical worsening or emergence of suicidal thoughts and behaviors. Fetzima is not approved for pediatric use.
Nausea, constipation, excessive sweating, rapid heart rate, erectile dysfunction, vomiting, and palpitations are some side effects that can occur with Fetzima medication. However, these are not the only side effects that can occur. Contact your doctor immediately if you have side effects that bother you or persist.
With a valid prescription from your doctor, you can buy Fetzima online here at a competitive price.
Fetzima. Madison, NJ: Allergan USA, Inc.; 2021.